Skip to main content
. Author manuscript; available in PMC: 2006 Jan 25.
Published in final edited form as: Pharmacogenet Genomics. 2005 Apr;15(4):245–256. doi: 10.1097/01213011-200504000-00008

Table 6.

Proposed FMO2 allele nomenclature

Allele Protein Genomic haplotype composition cDNA haplotype composition
FMO2*1a FMO2.1
FMO2*2a FMO2.2 g.23,238C > T c.1414C > T
FMO2*2Aa FMO2.2A [g.23,238C > T ; 23,412_23,413insT] [c.1414C > T ; 1588_1589insT]
FMO2*2B FMO2.2B [g.13,732C > T ; 23,238C > T] [c.584C > T ; 1414C > T]
FMO2*2C FMO2.2C [g.22,060T > G ; 23,238C > T] [c.1239T > G ; 1414C > T]
FMO2*2D FMO2.2D [g.13,732C > T ; 23,238C > T ; 23,412_23,413insT] [c.584C > T ; 1414C > T ; 1588_1589insT]
FMO2*2E FMO2.2E [g.10,951delG ; 13,732C > T ; 22,060T > G ; 23,238C > T] [c.337delG ; 584C > T ; 1239T > G ; 1414C > T]
FMO2*3 FMO2.3 g.22,060T > G c.1239T > G
a

These alleles have been previously described [15].